Rhenman & Partners Asset Management’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-804,649
| Closed | -$4.88M | – | 95 |
|
|
2024
Q3 | $4.88M | Sell |
804,649
-1,405
| -0.2% | -$8.51K | 0.4% | 65 |
|
|
2024
Q2 | $4.24M | Sell |
806,054
-105,766
| -12% | -$556K | 0.41% | 61 |
|
|
2024
Q1 | $7.74M | Buy |
911,820
+555,320
| +156% | +$4.71M | 0.73% | 47 |
|
|
2023
Q4 | $2.35M | Hold |
356,500
| – | – | 0.24% | 72 |
|
|
2023
Q3 | $1.1M | Hold |
356,500
| – | – | 0.12% | 81 |
|
|
2023
Q2 | $963K | Hold |
356,500
| – | – | 0.1% | 81 |
|
|
2023
Q1 | $1.05M | Sell |
356,500
-18,500
| -5% | -$54.6K | 0.12% | 83 |
|
|
2022
Q4 | $945K | Hold |
375,000
| – | – | 0.1% | 91 |
|
|
2022
Q3 | $1.35M | Hold |
375,000
| – | – | 0.14% | 88 |
|
|
2022
Q2 | $1.18M | Sell |
375,000
-35,923
| -9% | -$113K | 0.13% | 86 |
|
|
2022
Q1 | $2.54M | Sell |
410,923
-9,077
| -2% | -$56.1K | 0.25% | 82 |
|
|
2021
Q4 | $5.93M | Sell |
420,000
-180,000
| -30% | -$2.54M | 0.39% | 65 |
|
|
2021
Q3 | $4.8M | Buy |
600,000
+340,000
| +131% | +$2.72M | 0.34% | 76 |
|
|
2021
Q2 | $7.43M | Hold |
260,000
| – | – | 0.5% | 66 |
|
|
2021
Q1 | $7.55M | Buy |
260,000
+103,300
| +66% | +$3M | 0.53% | 58 |
|
|
2020
Q4 | $1.87M | Buy |
+156,700
| New | +$1.87M | 0.15% | 78 |
|